Fritextsökning
Innehållstyper
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Cantargia till klinik
”När vi har hittat en säker dos så kommer vi att välja vilken cancertyp som vi ska satsa på först. Vi räknar med att kunna fatta ett beslut om det under år 2017...
-
C-Rad till Stockholmsbörsen och tingsrätten
Tar klivet ut på Stockholmsbörsen och skyddar patent i tvist mot Baemocular.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Exhibitors
Register of exhibitors and where they can be found.
-
Osäker framtid för Chrontech
Crontechs kapital tar slut under andra kvartalet i år. Bolaget kan bara fortsätta verksamheten om det får in nya pengar via planerade nyemissioner.
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
Chrontech Pharma möblerar om
Flyttar hepatit-forskningen till ett dotterbolag och antar nytt fokus.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Cellavision utser USA-chef
Blodanalysbolaget expanderar verksamheten i Nordamerika.
-
Hallå där Truls Sjöstedt…
…vd för medtechbolaget Brighter som just nu genomför en nyemission för att ta in 16 miljoner kronor. Vad ska pengarna användas till?
-
CRO-fusion ska ge marknadsfördelar
Amerikansk CRO får tillgång till Europa och europeisk motsvarighet får vice versa i ny sammanslagning.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Förlängd överlevnad med cancervaccin
Göteborgsbolaget Immunicum rapporterar positiva resultat från studie i fas I/II.
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
Han blir ny vd på Bactiguard
Inför börsnoteringen kliver nuvarande vd:n åt sidan till förmån för exportexpert.
-
Dystra siffror för Hansa Medical
Visar upp ett lågt resultat men planerar nu fler kliniska studier med läkemedelskandidaten Ides.
BREAKING